Pubertal development in girls with sexual precocity after discontinuation of treatment with cyproterone acetate.
Twenty-four girls with sexual precocity who had been treated with cyproterone acetate were followed for periods from 1 to 8 1/2 years after the discontinuation of therapy. It was found that their further pubertal development and the resumption or appearance of menstruation followed a natural course within the wide limits of physiological variability. It is concluded that puberty resumes its natural course following cessation of treatment with cyproterone acetate, and it is assumed that the reproductive ability of these patients will not be affected.
D000293:Adolescent; D002648:Child; D003534:Cyproterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017373:Cyproterone Acetate; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008572:Menarche / Q000187:drug effects; D011627:Puberty / Q000187:drug effects*; D011629:Puberty, Precocious / Q000188:drug therapy*
D017373:Cyproterone Acetate; D003534:Cyproterone